CS logo
small CS logo
Hyogo Brain and Heart Center

Himeji, Hyogo, Japan
Government hospital in Himeji
甲520 Saisho, Himeji, Hyogo 670-0981

About Hyogo Brain and Heart Center


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Abbott Medical Devices
1
Bayer
1
Boston Scientific Corporation
1
Cook Group Incorporated
1
Juntendo University
1
Mebix Inc
1
Nippon Medical School
1
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
1
Total Rows: 8

Clinical Trials at Hyogo Brain and Heart Center


During the past decade, Hyogo Brain and Heart Center conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 4 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 3 clinical trials were completed. i.e. 150% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years11001122001100110011000000001111Started TrialsCompleted Trails201520162017201820192020202120220123
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Clinical Study Of Eplerenone In Japanese Patients With Chronic Heart Failure
2010-07-01
2015-09-01
Completed
221
The Cardiac Insufficiency BIsoprolol Study in Japanese Patients With Chronic Heart Failure (CIBIS-J)
2013-06-01
Unknown status
220
Zenith® TXD Post-market Surveillance in Japan
2015-03-01
2023-05-01
Active, not recruiting
57
Heart Failure and Sudden Cardiac Death Japan Registry
2017-07-21
2020-12-01
Completed
354
MitraClip NT System Post-marketing Surveillance Study - Japan
2018-04-02
2022-03-23
Completed
500
STroke Secondary Prevention With Catheter ABLation and EDoxaban for Patients With Non-valvular Atrial Fibrillation: STABLED Study
2018-04-01
2023-03-01
Unknown status
250
Study to Gather Information About the Proper Dosing and Safety of the Oral FXIa Inhibitor BAY 2433334 in Patients Following an Acute Heart Attack
2020-06-17
2022-02-21
Completed
1,601
Early Treatment With a Sodium-glucose Co-transporter 2 Inhibitor in High-risk Patients With Acute Heart Failure
2022-09-10
2024-06-30
Recruiting
500

Rows per page:

1–8 of 8

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Hyogo Brain and Heart Center" #1 sponsor was "Abbott Medical Devices" with 1 trials, followed by "Bayer" with 1 trials sponsored, "Boston Scientific Corporation" with 1 trials sponsored, "Cook Group Incorporated" with 1 trials sponsored and "Juntendo University" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Hyogo Brain and Heart Center" #1 collaborator was "Abbott" with 1 trials as a collaborator, "Boehringer Ingelheim" with 1 trials as a collaborator, "Daiichi Sankyo Co., Ltd." with 1 trials as a collaborator and "ICON Clinical Research" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.
Created with Highcharts 11.1.0Top Leading SponsorsAbbott Medical Devices: 1Abbott Medical Devices: 1Bayer: 1Bayer: 1Boston Scientific Corporation: 1Boston Scientific Corporation: 1Cook Group Incorporated: 1Cook Group Incorporated: 1Juntendo University: 1Juntendo University: 1Mebix Inc: 1Mebix Inc: 1Nippon Medical School: 1Nippon Medical School: 1Pfizer's Upjohn hasmerged with Mylan toform Viatris Inc.: 1Pfizer's Upjohn hasmerged with Mylan toform Viatris Inc.: 1

Created with Highcharts 11.1.0Top CollaboratorsAbbott: 1Abbott: 1Boehringer Ingelheim: 1Boehringer Ingelheim: 1Daiichi Sankyo Co., Ltd.: 1Daiichi Sankyo Co., Ltd.: 1ICON Clinical Research: 1ICON Clinical Research: 1

Clinical Trials Conditions at Hyogo Brain and Heart Center


According to Clinical.Site data, the most researched conditions in "Hyogo Brain and Heart Center" are "Heart Failure" (2 trials), "Acute Heart Failure" (1 trials), "Acute Myocardial Infarction" (1 trials), "Aortic Dissection" (1 trials) and "Arrhythmias, Cardiac" (1 trials). Many other conditions were trialed in "Hyogo Brain and Heart Center" in a lesser frequency.

Clinical Trials Intervention Types at Hyogo Brain and Heart Center


Most popular intervention types in "Hyogo Brain and Heart Center" are "Drug" (4 trials), "Device" (3 trials), "Other" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (2 trials), "BAY2433334" (1 trials), "BAY2433334 matching placebo" (1 trials), "Bisoprolol" (1 trials) and "CRT-D" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Hyogo Brain and Heart Center


The vast majority of trials in "Hyogo Brain and Heart Center" are 8 trials for "All" genders.

Clinical Trials Status at Hyogo Brain and Heart Center


Currently, there are NaN active trials in "Hyogo Brain and Heart Center". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Hyogo Brain and Heart Center, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Hyogo Brain and Heart Center, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 3Phase 3: 3Not Applicable: 1Not Applicable: 1Phase 2: 1Phase 2: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 4Completed: 4Unknown status: 2Unknown status: 2Active, not recruiting: 1Active, not recruiting: 1Recruiting: 1Recruiting: 1